4.65 DESTINY BREAST 04 - A complex trial to deconstruct

from Plenary Session - inactive due to federal service · host Vinay Prasad, MD MPH

My take on the standing ovation for DESTINY Breast 04 Traztuzumab Deruxtecan vs. Investigator choice after endocrine therapy and 1 or 2 chemotherapies for HER2 low

Episode metadata supplied by the publisher feed · Published Jun 7, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

4.65 DESTINY BREAST 04 - A complex trial to deconstruct

0:00 32:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Plenary Session - inactive due to federal service?

This episode is 32 minutes long.

When was this Plenary Session - inactive due to federal service episode published?

This episode was published on June 7, 2022.

Can I download this Plenary Session - inactive due to federal service episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!